David J. Araten

1.6k citations

40 papers · 1.1k indexed · h-index 16

Co-authors: Lucio Luzzatto Khédoudja Nafa Rosario Notaro Howard T. Thaler Anastasios Karadimitris David W. Golde Rong H. Zhang Lucia Gargiulo
Topics: Complement system in diseases (25 papers)Renal Diseases and Glomerulopathies (11 papers)Blood groups and transfusion (9 papers)
Cited by: Nephrology Hematology Immunology
Journals: Proceedings of the National Academy of Sciences Nucleic Acids Research Blood
Partner nations: United States Italy United Kingdom

In The Last Decade

David J. Araten

40 papers receiving 1.1k citations

Peers

Countries citing papers authored by David J. Araten

Since Specialization

Citations

This map shows the geographic impact of David J. Araten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David J. Araten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David J. Araten more than expected).

Fields of papers citing papers by David J. Araten

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David J. Araten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David J. Araten. The network helps show where David J. Araten may publish in the future.

Co-authorship network of co-authors of David J. Araten

This figure shows the co-authorship network connecting the top 25 collaborators of David J. Araten. A scholar is included among the top collaborators of David J. Araten based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David J. Araten. David J. Araten is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	PB2063: APPULSE-PNH: A PHASE IIIB TRIAL TO EVALUATE THE EFFICACY AND SAFETY OF SWITCHING TO IPTACOPAN IN PATIENTS WITH PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (PNH) ON ANTI-C5 THERAPY WITH HEMOGLOBIN >10G/DL 2023 ·HemaSphere ·Antonio M. Risitano,David J. Araten,David J. Kuter,Bhumika J. Patel,Régis Peffault de Latour,Marion Dahlke,(unknown),(unknown),Samopriyo Maitra,Austin Kulasekararaj	1
2	Composite endpoint to evaluate complement inhibition therapy in patients with paroxysmal nocturnal hemoglobinuria 2022 ·European Journal Of Haematology ·Austin Kulasekararaj,Axel Glasmacher,(unknown),Jeff Szer,David J. Araten,Geraldine Rauch,Chad Gwaltney,J. Rafael Sierra,Jong Wook Lee	5
3	Baseline clinical characteristics and disease burden in patients with paroxysmal nocturnal hemoglobinuria (PNH): updated analysis from the International PNH Registry 2020 ·Annals of Hematology ·Hubert Schrezenmeier,Alexander Röth,David J. Araten,Yuzuru Kanakura,Loree Larratt,Jamile M. Shammo,Amanda Wilson,(unknown),Jaroslaw P. Maciejewski	94
4	A patient with POEMS syndrome responding to modified CyBorD chemotherapy as a bridge to autologous stem cell transplantation 2019 ·JAAD Case Reports ·Emily C. Milam,Kathryn J. Martires,Kristen I. Lo Sicco,David J. Araten,Andrew G. Franks	1
5	Analysis of platelets by flow cytometry in patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) 2019 ·Blood Cells Molecules and Diseases ·David J. Araten,(unknown),(unknown),(unknown),Michael Nardi	4
6	Analysis of TET2 mutations in paroxysmal nocturnal hemoglobinuria (PNH) 2019 ·Experimental Hematology and Oncology ·Camille Lobry,(unknown),(unknown),Sherif Ibrahim,Iannis Aifantis,David J. Araten	2
7	MSH6 haploinsufficiency at relapse contributes to the development of thiopurine resistance in pediatric B-lymphoblastic leukemia 2018 ·Haematologica ·Nikki A. Evensen,(unknown),Julia Meyer,(unknown),(unknown),David J. Araten,Jacob Nersting,Teena Bhatla,Tiffaney L. Vincent,David T. Teachey,Stephen P. Hunger,Jun J. Yang,Kjeld Schmiegelow,William L. Carroll	28
8	Selective splenic artery embolization for the treatment of thrombocytopenia and hypersplenism in paroxysmal nocturnal hemoglobinuria 2014 ·Journal of Hematology & Oncology ·David J. Araten,Anna Paola Iori,Karen T. Brown,G Torelli,Walter Barberi,(unknown),(unknown),Corrado Girmenia,Filippo Maria Salvatori,Orly Zelig,Robin Foà,Lucio Luzzatto	13
9	Leukemic Blasts with the Paroxysmal Nocturnal Hemoglobinuria Phenotype in Children with Acute Lymphoblastic Leukemia 2012 ·American Journal Of Pathology ·David J. Araten,Katie Sanders,(unknown),(unknown),Stephen P. Hunger,Sherif Ibrahim	4
10	Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature 2011 ·Haematologica ·David J. Araten,Rosario Notaro,Howard T. Thaler,Nancy A. Kernan,Farid Boulad,Hugo Castro‐Malaspina,Trudy N. Small,Andromachi Scaradavou,Heather Magnan,Susan E. Prockop,Sara Chaffee,(unknown),Raymond Thertulien,Roberto Tarquini,Lucio Luzzatto	20
11	Paroxysmal nocturnal hemoglobinuria in pediatric patients 2011 ·Pediatric Blood & Cancer ·Kevin J. Curran,Nancy A. Kernan,Susan E. Prockop,Andromachi Scaradavou,Trudy N. Small,Rachel Kobos,Hugo Castro‐Malaspina,David J. Araten,Donna DiMichele,Richard J. O’Reilly,Farid Boulad	31
12	A quantitative analysis of genomic instability in lymphoid and plasma cell neoplasms based on the PIG-A gene 2010 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·David J. Araten,José A. Martínez-Climent,Mary Ann Perle,(unknown),(unknown),(unknown),Katie Sanders	11
13	The use of PIG-A as a sentinel gene for the study of the somatic mutation rate and of mutagenic agents in vivo 2009 ·Mutation Research/Reviews in Mutation Research ·Benedetta Peruzzi,David J. Araten,Rosario Notaro,Lucio Luzzatto	47
14	Splenic infarction and subsequent splenic rupture in a patient with paroxysmal nocturnal hemoglobinuria and heparin‐induced thrombocytopenia 2009 ·Pediatric Blood & Cancer ·Heather Magnan,Mark L. Kayton,Donna DiMichele,David J. Araten,Nancy A. Kernan,Farid Boulad	5
15	Spontaneously arising red cells with a McLeod-like phenotype in normal donors 2009 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·David J. Araten,Katie Sanders,Jeffrey J. Pu,Soohee Lee	2
16	High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria 2004 ·Thrombosis and Haemostasis ·Howard T. Thaler,Lucio Luzzatto,David J. Araten	39
17	Cytogenetic and morphological abnormalities in paroxysmal nocturnal haemoglobinuria 2001 ·British Journal of Haematology ·David J. Araten,David Swirsky,Anastasios Karadimitris,Rosario Notaro,Khédoudja Nafa,Monica Bessler,Howard T. Thaler,Hugo Castro‐Malaspina,Barrett H. Childs,Farid Boulad,Mark A. Weiss,Nikolaos Anagnostopoulos,Abdullah Kutlar,David G. Savage,Richard T. Maziarz,Suresh C. Jhanwar,Lucio Luzzatto	34
18	Association of clonal T‐cell large granular lymphocyte disease and paroxysmal nocturnal haemoglobinuria (PNH): further evidence for a pathogenetic link between T cells, aplastic anaemia and PNH 2001 ·British Journal of Haematology ·Anastasios Karadimitris,Ke Li,Rosario Notaro,David J. Araten,Khédoudja Nafa,Raymond Thertulien,Marc Ladanyi,(unknown),(unknown),(unknown),Lucio Luzzatto	41
19	Abnormal T-cell repertoire is consistent with immune process underlying the pathogenesis of paroxysmal nocturnal hemoglobinuria 2000 ·Blood ·Anastasios Karadimitris,John S. Manavalan,Howard T. Thaler,Rosario Notaro,David J. Araten,Khédoudja Nafa,Irene Roberts,Marc E. Weksler,Lucio Luzzatto	96
20	IN VITRO ALLOREACTIVITY AGAINST HOST ANTIGENS IN AN ADULT HLA-MISMATCHED BONE MARROW TRANSPLANT RECIPIENT DESPITE IN VIVO HOST TOLERANCE 1993 ·Transplantation ·David J. Araten,Trebor Lawton,James L.M. Ferrara,(unknown),Edgar L. Milford,Charles B. Carpenter,Richard T. Maziarz	4

About David J. Araten

David J. Araten is a scholar working on Hematology, Nephrology and Genetics, having authored 40 papers that have together received 1.1k indexed citations. Recurring topics across this work include Complement system in diseases (25 papers), Renal Diseases and Glomerulopathies (11 papers) and Blood groups and transfusion (9 papers). The work is most often cited by research in Nephrology (353 citations), Hematology (424 citations) and Immunology (698 citations). David J. Araten has collaborated with scholars based in United States, Italy and United Kingdom. Frequent co-authors include Lucio Luzzatto, Khédoudja Nafa, Rosario Notaro, Howard T. Thaler, Anastasios Karadimitris, David W. Golde, Rong H. Zhang, Lucia Gargiulo, Amanda Wilson and Alexander Röth. Their work appears in journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact